The article presents the characteristics of the Dimebon drug, different ways of drug delivery to organs and tissues. The purpose of this study was to determine the Dimebon gel effect on inflammation in experimental animals in comparison with other gels. It was found the criteria of evaluation and formulation of algorithms experiment. It was revealed the absence of systemic toxicity of the Dimebon gel, the severity of their de-congestant effect (77.04%) and a superior action with microcapsules Dimebon (69.63%). The Dimebon gel is not inferior to the Fenistil gel. This is explained by the action of the test Dimebon, because the effectiveness of gel base in 3,2 times is inferior to the subject gel. Regenerative activity the Dimebon gel is controlled burn time of rejection of the scab, which was lower by 2 days than when using the Fenistil gel and 4 days after the Dimebon gel microcapsules.
the Dimebon, gel, inflammation, the Fenistil, transdermal routes of administration
1. Belyaeva E.A., Kupeev V.G., Khadartsev A.A. Novaya tekhnologiya bezopasnosti analgeticheskoy terapii pri oslozhnennom osteoporoze. Vestnik novykh meditsinskikh tekhnologiy. 2010. T.17, №3. S. 122-124.
2. Bekhtereva T.L., Borisova O.N., Vigdorchik V.I., Koryakin A.A., Fudin N.A., Khadartsev A.A. Obosnovanie sposoba elektrolazernoy miostimulyatsii i lazeroforeza. Vestnik novykh meditsinskikh tekhnologiy. 2004. T.11, №1-2, S. 66-68.
3. Vybor optimal´noy kompozitsii vspomogatel´nykh veshchestv dermatologicheskikh lekarstvennykh form s dimebonom: biofarmatsevticheskie issledovaniya in vitro / Koryanova K.N. [i dr.]. Mezhdunarodnyy zhurnal prikladnykh i fundamental´nykh issledovaniy. 2010. №5. S. 41-45.
4. Il´yuchenok T.I., Matveeva I.A. Dimebon - novyy antigistaminnyy preparat. Novye lekarstvennye preparaty 1989. №4. S. 12-14.
5. Perspektivy ispol´zovaniya dermatologicheskikh lekartsvennykh form s dimebonom v kosmetologii / Koryanova K.N. [i dr.]. Zaporozhskiy meditsinskiy zhurnal. 2011. T. 13, №3. S. 132-133.
6. Razrabotka dermatologicheskiy lekarstvennykh form s dimebonom / Koryanova K.N. [i dr.]. Raz-rabotka, issledovanie i marketing novoy farmatsevticheskoy produktsii: sb. nauch. tr. Pyatigorsk: GFA, 2011. Vyp. 66. S. 276-278.
7. Ryazanova E.A., Khadartsev A.A. Lazeroforez gialuronovoy kisloty v profilaktike i vosstanovitel´noy terapii anrusheniy funktsii kozhi. Fundamental´nye issledovaniya. 2006. №9. S. 69.
8. Tutel´yan V.A., Zilov V.G., Khadartsev A.A., Es´kov V.M., Fudin N.A., Kidalov V.N., Kartashova N.M., Chub S.G., Naumova E.M., Yakushina G.N., Oleynikova M.M., Valentinov B.G., Mitrofanov I.V. Teoriya i praktika vosstanovitel´noy meditsiny. Tula, T. 1, 2004.
9. Khabriev R.U. Rukovodstvo po eksperimental´nom (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv. M., 2005. 458 s.
10. Khadartsev A.A. Izbrannye tekhnologii nemedikamentoznogo vozdeystviya v reabilitatsionno-vosstanovitel´noy i sportivnoy meditsine / Pod. Red. Fudina N.A. Tula, 2009.
11. Khadartsev A.A., Kupeev V.G., Oleynikova M.M., Borisova O.N., Naumova E.M. Koronatera v so-chetanii s lazeroforezom fitomelanina pri stenokardii napryazheniya. Vestnik novykh meditsinskikh tekhnologiy. 2012. T. 19, №1. S. 92-95.
12. Khadartsev A.A., Morozov V.N., Khrupachev A.G., Karaseva Yu.V., Morozova V.I. Depressiya anti-stressovykh mekhanizmov kak osnova razvitiya patologicheskogo protsessa. Fundamental´nye issledovaniya. 2012. №2-4. S. 371-375.
